Kyowa will co-promote the drug in the US if approved, with opt-in rights in some other countries as well. Amgen pays Kyowa $400m upfront for OX40 eczema drug | pharmaphorum Skip to main content ...

SQUEEZE OUT EVERY DROP OF JUICE: Our lemon squeezer won’t waste even a single drop from your favorite fruit and will also leave the seeds and pulp behind! The 5-inch diameter of the citrus press ...

Abstract: In this paper, a Multi-Criteria Decision-Making (MCDM) tool which combines Fuzzy Set Theory (FST) with TOPSIS (Fuzzy TOPSIS) is presented for selecting optimal material for the different ...

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world ...